Table 1: Response to neoadjuvant chemotherapy in 92 patients with NPC.

Response Number of patients
NP
()
LN
()
Combination
(NP + LN)

Responders
 Complete response24 (26.1%)44 (55.0%)20 (21.7%)
 Partial response55 (59.8%)26 (32.5%)56 (60.9%)
Nonresponders
 Stable disease13 (14.1%)10 (12.5%)16 (17.4%)
 Progressive disease0 (0%)0 (0%)0 (0%)

NP = nasopharynx; LN = regional neck lymph nodes.
12 patients with N0 disease were not included in the analysis.